Bronchopulmonary dysplasia – a new perspective on prevention and treatment
DOI:
https://doi.org/10.12775/JEHS.2023.41.01.011Keywords
bronchopulmonary dysplasia, chronic lung disease, preterm birth, neonatal care, stem cells, pulmonary hypertensionAbstract
Introduction
Premature birth is one of the most common problems in neonatal care and affects from 6 to 14% of pregnancies (frequency depends on geographical factors) [1]. Prematurity is the cause of almost half of deaths of children younger than 5 years old [3]. The most frequent and one of the most severe risks of preterm births is bronchopulmonary dysplasia (also called a chronic lung disease in some sources).
Aim of the study
The aim of this study is to collect data on both new and traditional ways of prevention and treatment of chronic lung disease in a population of infants born preterm (<37 weeks of gestational age).
Materials and methods
The work was created based on the articles available in PubMed and Google Scholar databases and available scientific literature. Publications were searched in English and Polish using the following keywords: bronchopulmonary dysplasia, chronic lung disease of the newborns, pulmonary hypertension in bronchopulmonary dysplasia, stem cells in bronchopulmonary dysplasia.
Results
Although bronchopulmonary dysplasia is a common problem among children born preterm, there is still a limited amount of possibilities of prevention and treatment of this condition. Despite efforts of scientists, many children with this condition suffer from both short-term and long-term consequences, such as frequent infections, asthma and impaired growth and neurodevelopment.
Summary
In the last twenty years the survival rate of children born preterm rapidly increased thank to the development of neonatal care. Up to 20% of children born with body weight less than 1500g will develop bronchopulmonary dysplasia. That is why there is a need for further research on the topic of bronchopulmonary dysplasia management, especially when it comes to biomarkers, use of mesenchymal stem cells and treatment of pulmonary hypertension.
References
Thébaud, B., Goss, K.N., Laughon, M. et al. Bronchopulmonary dysplasia. Nat Rev Dis Primers 5, 78 (2019). https://doi.org/10.1038/s41572-019-0127-7
Álvarez-Fuente, M., Moreno, L., Mitchell, J.A. et al. Preventing bronchopulmonary dysplasia: new tools for an old challenge. Pediatr Res 85, 432–441 (2019). https://doi.org/10.1038/s41390-018-0228-0
Rüdiger, M., Kirpalani, H., Steinhorn, R. et al. How to introduce MSC-based therapy for the developing lung safely into clinical care?. Pediatr Res 88, 365–368 (2020). https://doi.org/10.1038/s41390-020-0758-0
Hansmann, G., Sallmon, H., Roehr, C.C. et al. Pulmonary hypertension in bronchopulmonary dysplasia. Pediatr Res 89, 446–455 (2021). https://doi.org/10.1038/s41390-020-0993-4
Durlak, W., Thébaud, B. The vascular phenotype of BPD: new basic science insights—new precision medicine approaches. Pediatr Res (2022). https://doi.org/10.1038/s41390-022-02428-7
Salaets, T., Tack, B., Jimenez, J. et al. Simvastatin attenuates lung functional and vascular effects of hyperoxia in preterm rabbits. Pediatr Res 87, 1193–1200 (2020). https://doi.org/10.1038/s41390-019-0711-2
Edyta Głowacka, Grzegorz Lis, Bronchopulmonary dysplasia — early and long-term pulmonary sequelae, Pneumonol. Alergol. Pol. 2008; 76: 437–445
Ewa Helwich, Dysplazja oskrzelowo-płucna [Bronchopulmonary dysplasia], Pediatr Dypl. 2013;17(wyd. spec.): 13-18, Polish
Dobrzańska A, Gadzinowski J, Helwich E i wsp., Stanowisko Grupy Ekspertów w sprawie stosowania surfaktantu u noworodków i dzieci. [Guidelines of polish group of experts on use of surfactant in newborns and children], Standardy Med. 2011;4(8): 526-534. Polish
Sweet D, Carnielli V, Greisen G, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants – 2010 update. Neonatology. 2010; 97:402 - 417.
Rutkowska M, Helwich E, Borecka R. Częstość zakażeń układu oddechowego u dzieci z dysplazją oskrzelowo-płucną otrzymujących profilaktycznie paliwizumab. [Frequency of respiratory infections among children with bronchopulmonary dysplasia who get paliwizumab as a profilactic measure.] Ped Pol. 2011;86(4):317-325. Polish
Surate Solaligue, D. E., Rodriguez-Castillo, J. A., Ahlbrecht, K. & Morty, R. E. Recent advances in our understanding of the mechanisms of late lung development and bronchopulmonary dysplasia. Am. J. Physiol. Lung Cell Mol. Physiol. 313, L1101–L1153 (2017).
Hansen AR, Barnés CM, Folkman J, McElrath TF. Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. J Pediatr. 2010 Apr;156(4):532-6. doi: 10.1016/j.jpeds.2009.10.018. Epub 2009 Dec 14. PMID: 20004912.
Zhang ZQ, Huang XM, Lu H. Early biomarkers as predictors for bronchopulmonary dysplasia in preterm infants: a systematic review. Eur J Pediatr. 2014 Jan;173(1):15-23. doi: 10.1007/s00431-013-2148-7. Epub 2013 Sep 1. PMID: 23996017.
Blok CA, Krediet TG, Kavelaars A, Koopman-Esseboom C, Vreman HJ, Van Bel F. Early end-tidal carbon monoxide levels and neurodevelopmental outcome at 3 years 6 months of age in preterm infants. Dev Med Child Neurol. 2011 Dec;53(12):1113-8. doi: 10.1111/j.1469-8749.2011.04110.x. Epub 2011 Sep 20. PMID: 21933176; PMCID: PMC3220782.
Cheong JLY, Doyle LW. An update on pulmonary and neurodevelopmental outcomes of bronchopulmonary dysplasia. Semin Perinatol. 2018 Nov;42(7):478-484. doi: 10.1053/j.semperi.2018.09.013. Epub 2018 Oct 2. PMID: 30401478.
Anderson PJ, Doyle LW. Neurodevelopmental outcome of bronchopulmonary dysplasia. Semin Perinatol. 2006 Aug;30(4):227-32. doi: 10.1053/j.semperi.2006.05.010. PMID: 16860163.
Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017 Mar 21;3(3):CD004454. doi: 10.1002/14651858.CD004454.pub3. Update in: Cochrane Database Syst Rev. 2020 Dec 25;12:CD004454. PMID: 28321847; PMCID: PMC6464568.
Nuytten A, Behal H, Duhamel A, Jarreau PH, Mazela J, Milligan D, Gortner L, Piedvache A, Zeitlin J, Truffert P; EPICE (Effective Perinatal Intensive Care in Europe) Research Group. Evidence-Based Neonatal Unit Practices and Determinants of Postnatal Corticosteroid-Use in Preterm Births below 30 Weeks GA in Europe. A Population-Based Cohort Study. PLoS One. 2017 Jan 23;12(1): e0170234. doi: 10.1371/journal.pone.0170234. Erratum in: PLoS One. 2017 Feb 13;12 (2): e0172408. PMID: 28114369; PMCID: PMC5256868.
Shaffer ML, Baud O, Lacaze-Masmonteil T, Peltoniemi OM, Bonsante F, Watterberg KL. Effect of Prophylaxis for Early Adrenal Insufficiency Using Low-Dose Hydrocortisone in Very Preterm Infants: An Individual Patient Data Meta-Analysis. J Pediatr. 2019 Apr; 207:136 - 142.e5. doi: 10.1016/j.jpeds.2018.10.004. Epub 2018 Nov 8. PMID: 30416014.
Bassler D, Shinwell ES, Hallman M, Jarreau PH, Plavka R, Carnielli V, Meisner C, Engel C, Koch A, Kreutzer K, van den Anker JN, Schwab M, Halliday HL, Poets CF; Neonatal European Study of Inhaled Steroids Trial Group. Long-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia. N Engl J Med. 2018 Jan 11;378(2):148-157. doi: 10.1056/NEJMoa1708831. PMID: 29320647.
Askie LM, Ballard RA, Cutter GR, Dani C, Elbourne D, Field D, Hascoet JM, Hibbs AM, Kinsella JP, Mercier JC, Rich W, Schreiber MD, Wongsiridej PS, Subhedar NV, Van Meurs KP, Voysey M, Barrington K, Ehrenkranz RA, Finer NN; Meta-analysis of Preterm Patients on Inhaled Nitric Oxide Collaboration. Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trials. Pediatrics. 2011 Oct;128(4):729-39. doi: 10.1542/peds.2010-2725. Epub 2011 Sep 19. PMID: 21930540; PMCID: PMC3387905.
Lewandowski AJ, Bradlow WM, Augustine D, Davis EF, Francis J, Singhal A, Lucas A, Neubauer S, McCormick K, Leeson P. Right ventricular systolic dysfunction in young adults born preterm. Circulation. 2013 Aug 13;128(7):713-20. doi: 10.1161/CIRCULATIONAHA.113.002583. PMID: 23940387.
Sipola-Leppänen M, Vääräsmäki M, Tikanmäki M, Hovi P, Miettola S, Ruokonen A, Pouta A, Järvelin MR, Kajantie E. Cardiovascular risk factors in adolescents born preterm. Pediatrics. 2014 Oct;134(4): e1072-81. doi: 10.1542/peds.2013-4186. Epub 2014 Sep 1. PMID: 25180275.
Principi N, Di Pietro GM, Esposito S. Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies. J Transl Med. 2018 Feb 20;16(1):36. doi: 10.1186/s12967-018-1417-7. PMID: 29463286; PMCID: PMC5819643.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Aleksandra Grabarczyk, Anna Jaremek, Joanna Kępa, Norbert Kandefer, Michał Wyszkowski, Anna Pawlak, Sylwia Grad, Małgorzata Gregorek, Paweł Gregorek
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 448
Number of citations: 0